Page 29 - FINAL PROGRAM

PRECONGRESS COURSE 07
Sunday, 3 July 2016 I Hall 3 D
Endometriosis – getting research from bench to bedside
Organised by the Special Interest Group Endometriosis and Endometrium
COURSE COORDINATORS
Andrew Horne (United Kingdom), Andrea Romano (The Netherlands), Gerard Dunselman (The Netherlands), Carla Tomassetti (Belgium)
COURSE DESCRIPTION
This course aims to provide
• an overview of current treatment approaches for endometriosis
• review current laboratory approaches to identify new treatments
• review speci c therapeutics currently under research
• examine the challenges of moving endometriosis research from the laboratory into the clinical setting.
TARGET AUDIENCE
Clinicians, researchers and patients with an interest in the endometrium and endometriosis.
EDUCATIONAL NEEDS AND EXPECTED OUTCOMES
The course should provide you with
• a summary of the effectiveness of current treatments for endometriosis
• an in-depth understanding of the laboratory models being used to try to identify new treatments
• an update of speci c therapeutics currently under research
• an understanding of the challenges faced by researchers of moving endometriosis research from the
laboratory
09:00 - 09:30 09:30 - 09:45 09:45 - 10:15
10:15 - 10:30 10:30 - 11:00 11:00 - 11:30 11:30 - 11:45 11:45 - 12:15 12:15 - 12:30 12:30 - 13:30 13:30 - 14:00 14:00 - 14:15 14:15 - 14:45
14:45 - 15:00 15:00 - 15:30 15:30 - 16:00
16:00 - 16:15 16:15 - 16:45
16:45 - 17:00
into the clinical setting.
Evidence for current medical therapies for endometriosis – Paolo Vercellini (Italy) Discussion
Laboratory models for identifying new drug targets for endometriosis – Erin Greaves (United Kingdom)
Discussion
Coffee break
Anti-angiogenesis treatment – Robert N. Taylor (U.S.A.)
Discussion
Estrogen-dependent therapies – Andrea Romano (The Netherlands) Discussion
Lunch break
Selective progesterone receptor modulators – Philippe Bouchard (France)
Discussion
Is there evidence to support the use of neuropathic adjunctive analgesics in endometriosis- associated pain? – Katy Vincent (United Kingdom)
Discussion
Coffee break
Novel orally active GnRH antagonists for the management of pain in endometriosis – Kristof Chwalisz (U.S.A.)
Discussion
The challenges of moving endometriosis research from the lab into the clinic –
Patrick Groothuis (The Netherlands)
Discussion
FINAL PROGRAMME I HELSINKI, FINLAND – 3 TO 6 JULY 2016 25
PRECONGRESS COURSES